Sandoz Recalls Drugs Made at Mylan India Site

Source: Economic Times of India

Feb 25, 2016

U.S.-based Sandoz, the generic pharmaceuticals division of Novartis, is recalling 270,000 bottles of hypertension tablets, manufactured by Hyderabad-based Mylan Laboratories, from the American market.

The recall involves bottles of Candesartan Cilexetil tablets that failed to meet impurities/degradation specifications and 9-month stability time point.
Candesartan Cilexetil is a generic verison of AstraZeneca's blood pressure drug Atacand.

In November 2015, Sandoz recalled the same drug manufactured from the same Mylan facility, for similar reasons.

Read the ET article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments